Alon Izmirli is a seasoned technology executive with extensive experience in leadership roles across various sectors, particularly in medical technology and cybersecurity. Currently serving as VP R&D and CTO at MyHomeDoc since June 2020, Alon has successfully led a management transition, transformed product offerings, and expedited FDA and CE approval processes. As the Founder and CEO of SophisticMED, Alon focuses on cost reduction in healthcare through innovative solutions to reduce delirium in elderly patients. Alon's prior roles include Chief Technology Officer at GluSense Medical, Director of the Algorithm Department and Chief Scientist at MediGuide, and Software Design Engineer at Microsoft, among others. Alon possesses an MBA from the Technion - Israel Institute of Technology and a BS in Physics, Mathematics, and Computers from The Hebrew University of Jerusalem.
This person is not in any teams
This person is not in any offices
NONAGON
In a world where telehealth is becoming increasingly center stage, the shortcomings of the pre-existing model point to the need for a more seamless experience for everyone. There needs to be a way to integrate physical exams into the process in a way that gives patients the option to choose how they want to receive their care, and when. It needs to be user-friendly for the patient and convenient for the physician, not to mention, the technological necessity for powerful, but simple admin tools and hybrid system architecture that integrate with any proprietary healthcare system to pull it all together. Everything needs to merge and align together. And that’s the origin story of Nonagon. The attention to user experience, simplicity, and efficiency while offering a robust suite of services that can be seen at every level. From the symbiotic device to the app to the system architecture. Everything has been considered—as has everyone involved. And that’s why, with Nonagon, care is always at hand.